Dr Ken Gillman, MD
Critical independent evaluations in psycho-pharmacology
Menu
In brief This seems to be the latest in a persistently limp and desperate series of ‘new’ anti-depressants with ‘faster-better’ AD action. Evidence for any usefully novel action or efficacy…
1. Patients with previous episodes of severe depression (especially if it was unresponsive, or only partially responsive, to an SSRI)2. Those whose current episode is severe or shows psychomotor retardation…
This commentary covers Selegiline, rasagiline, and moclobemide which is far as I know are the only such drugs are available, although others, such as ladostigil, are on the horizon.First, one…
PsychoTropical is a knowledge and education resource started by Dr Gillman about 20 years ago. It is neither connected with, nor influenced by, any financial backing or interest group of any sort. The opinions expressed relate to Dr Gillman’s special knowledge and expertise as a recognised world-expert in MAOIs and serotonin toxicity.
© PsychoTropical 2022. All Rights Reserved